Circulating adrenomedullin in cirrhosis: Relationship to hyperdynamic circulation

Journal of Hepatology

Volumn 29, Issue 2, 1998, Pages 250-256

  Fernández Rodriguez, Conrado M ^d   Prada, Ignacio R ^d   Prieto, Jesús ^c   Montuenga, Luis M ^a   Elsasser, Ted ^b   Quiroga, Jorge ^d   Moreiras, Mercedes ^d   Andrade, Amalia ^d   Cuttitta, Frank ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d NONE

Author keywords

Adrenomedullin; Cirrhosis; Peripheral vasodilation

Indexed keywords

ADRENOMEDULLIN; CREATININE;

ADULT; ARTERY DILATATION; ARTICLE; CIRCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; FEMALE; HEMODYNAMICS; HUMAN; LIVER CIRRHOSIS; MALE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; SODIUM RETENTION; SYSTEMIC VASCULAR RESISTANCE; WATER RETENTION;

EID: 17544391105     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80010-X     Document Type: Article

References (49)

1. Schrier RW, Arroyo J, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention. Hepatology. 8:1988;1151-1157.
2. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide. Lancet. 337:1991;776-778.
3. Clariá J, Jimenez W, Ros J, Asbert M, Castro A, Arroyo V, et al. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide. Hepatology. 15:1992;343-349.
4. ω-Nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology. 17:1993;84-90.
5. Vorobioff J, Bredfeldt JE, Groszmann RJ. Increased blood flow through portal system in cirrhotic rats. Gastroenterology. 87:1984;1120-1126.
6. Cahill PA, Foster C, Redmond EM, Cingalewski C, Wu Y, Sitzman JV. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology. 22:1995;598-606.
7. Weigert AL, Martin PY, Niederberger M, Higa EMS, McMurtry IF, Ginés P, et al. Endothelium-dependent vascular hyporesponsiveness without detection of nitric oxide synthase induction in aorta of cirrhotic rats. Hepatology. 22:1995;1856-1862.
8. Castro A, Jimenez W, Clariá J, Ros J, Martínez JM, Bosch M, et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: a role of nitric oxide. Hepatology. 18:1993;367-372.
9. Ros J, Jimenez W, Lamas S, Claria J, Arroyo V, Rivera F, et al. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology. 21:1995;554-560.
10. Clariá J, Jimenez W, Ros J, Rigol M, Angeli P, Arroyo V, et al. Increased nitric-oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology. 20:1994;1615-1621.
11. Albillos A, Rossi I, Cacho G, Martínez MU, Millán I, Abreu L, et al. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol. 263:1995;G459-G464.
12. Kanwar S, Kubes P, Tepperman B, Lee SS. Nitric oxide activity in portal-hypertensive and cirrhotic rats. J Hepatol. 25:1996;85-89.
13. Fernández M, Garcia-Pagan JC, Casadevall M, Bernadich C, Piera C, Whittle BJ, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology. 108:1995;1487-1495.
14. Niederberger, Martin PY, Ginés P, Morris K, Tsai Ph, Li Xu D, et al. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology. 109:1995;1624-1630.
15. Niederberger M, Ginés P, Martin PY, Tsai Ph, Morris K, McMurtry I, et al. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology. 24:1996;947-951.
16. Sogni P, Moreau R, Gadano A, Lebrec D. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. J Hepatol. 23:1995;218-224.
17. Fernández-Rodriguez CM, Prieto J, Quiroga J, Zozaya JM, Andrade A, Núñez M, et al. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion. Hepatology. 21:1995;35-40.
18. Bendtsen F, Schifter S, Henriksen JH. Increased circulating calcitonin gen-related peptide in cirrhosis. J Hepatol. 12:1991;118-123.
19. Kitamura K, Kangawa K, Matsuo H, Eto T. Adrenomedullin. Implications for hypertension research. Drugs. 49:1995;485-495.
20. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 192:1993;553-560.
21. Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, et al. Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun. 201:1994;1160-1166.
22. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H, Eto T. Distribution and characterization of adrenomedullin in human tissue and plasma. FEBS Lett. 338:1994;6-10.
23. Sharp D. Adrenomedullin: hypertension-control contender? Lancet. 348:1996;47.
24. Yanagisawa M. The endothelin system, a new target for therapeutic intervention. Circulation. 89:1994;1320-1322.
25. Feng Ch, Kang B, Kaye AD, Kadowitz PJ, Nossaman BD. L-NAME modulates responses to adrenomedullin in the hindquarters vascular beds of the rat. Life Sci. 55:1994;433-438.
26. Guevara M, Ginés P, Jiménez W, Sort P, Ros J, Fernández-Esparrach G, et al. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. Gastroenterology. 114:1998;336-343.
27. Cheung B, Leung R. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci. 92:1997;59-62.
28. Fábrega E, Casafont F, Crespo J, De la Peña J, San Miguel G, de las Heras G, et al. Plasma adrenomedullin levels in patients with hepatic cirrhosis. Am J Gastroenterol. 92:1997;1901-1904.
29. Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding varices. Br J Surg. 60:1973;646-649.
30. Arroyo V, Ginés P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 23:1996;164-175.
31. Livesey JH, Donald RA. Prevention of adsorption losses during radioimmunoassay of polypeptides hormones: effectiveness of albumins, gelatin, caseins, Tween 20 and plasma. Clin Chem Acta. 123:1982;193-198.
32. Fisher DC, Sahn DJ, Friedman MJ, Larson D, Valdés-Cruz LM, Horowitz S, et al. The effects of variations on pulsed droppler sampling site on calculation of cardiac output, an experimental study in open-chest dogs. Circulation. 67:1983;370-376.
33. Magnin PA, Stewart JA, Myers S, Vonramm O, Kisslo JA. Combined Doppler and phased-assay echocardiographic estimation of cardiac output. Circulation. 63:1980;388-392.
34. Huntsman LL, Stewart DK, Barnes SR, Franklin SB, Colocousis JS, Hessel EA. Noninvasive Doppler determination of cardiac output in man: clinical validation. Circulation. 67:1983;593-599.
35. Pinto P, American J, Reynolds TB. Large-volume paracentesis in non-edematous patients with tense ascites. Hepatology. 8:1988;207-210.
36. Kato J, Kitamura K, Kangawa K, Eto E. Receptors for adrenomedullin in human vascular endothelial cells. Eur J Pharmacol. 289:1995;383-385.
37. Fernández-Rodriguez CM, Prieto J, Zozaya JM, Quiroga J, Guitián R. Arteriovenous shunting, hemodynamic changes and renal soduim retention in liver cirrhosis. Gastroenterology. 104:1993;1139-1145.
38. López C, Jiménez W, Arroyo V, Claria J, La Villa G, Asbert M, et al. Temporal relationship between the decrease in arterial pressure and sodium retention in conscious spontaneously hypertensive rats with carbon tetrachloride-induced cirrhosis. Hepatology. 13:1991;585-589.
39. Ishimitsu T. Plasma levels of adrenomedullin, a new identified hypotensive peptide in patients with hypertension and renal failure. J Clin Invest. 94:1994;2158-2161.
40. Bourgoignie J, Valle GA. Endotoxin and renal dysfunction in liver diseases. Epstein M. 3rd ed. The Kidney in Liver Diseases. 1988;486-507 Williams & Wilkins, Baltimore, MD.
41. Campillo B, Bories PN, Benvenutti C, Dupeyron C. Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation. J Hepatol. 24:1996;707-714.
42. Le Moine O, Soupison T, Sogni P, Marchant A, Moreau R, Hadengue A, et al. Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis. J Hepatol. 23:1995;391-395.
43. Fernández-Rodriguez CM, Sopeña B, Valverde C, Quiroga J, Rodriguez D, Prada I, et al. Circulating TNF-α, hemodynamic, vasoactive and renal function changes in cirrhosis (abstract). Gut. 37:1995;24. (Suppl 2).
44. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, et al. Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by TNF-α Biochem Biophys Res Comm. 203:1994;719-726.
45. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med. 327:1992;1774-1778.
46. Fernandez-Rodriguez CM, Prieto J, Quiroga J, Prada I, Rodriguez D, Pereira S, et al. Actividad nerviosa simpactica en la cirrosis: relacion con la hemodinamica periferica y cambios en la funcion renal. Gastroenterol Hepatol. 19:1996;194-198.
47. Sugo S, Minamino N, Shoji H, Kangawa K, Matsuo H. Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett. 369:1995;311-314.
48. Quiroga J, Sangro B, Núẽz M, Bilbao I, Longo J, Garcia-Villarreal L, et al. Transjugular intrahepatic porto-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology. 21:1995;986-994.
49. Martin Py, Li Xu D, Niederberger M, Weigert A, Tsai P, John J St, et al. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol. 270:1996;F494-F499.